Company Filing History:
Years Active: 2022-2025
Title: Innovations and Contributions of Inventor Elena Kagan
Introduction
Elena Kagan is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of medicine, particularly in the treatment of major depressive disorder. With a total of eight patents to her name, Kagan's work has had a profound impact on mental health treatment.
Latest Patents
Among her latest patents is a groundbreaking invention related to esketamine for use in treating major depressive disorder. This invention provides a dosage regimen for the safe and efficacious administration of esketamine and rapid-acting antidepressants in the treatment of major depressive disorder (MDD). Additionally, she has developed a method for the safe and efficacious administration of esketamine, further enhancing treatment options for patients suffering from this condition.
Career Highlights
Throughout her career, Kagan has worked with notable companies such as Clexio Biosciences Ltd. and Teva Pharmaceutical Industries Limited. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Elena Kagan has collaborated with several professionals in her field, including Gina Pastino and Petra Luise Goelzer. These collaborations have fostered a productive environment for innovation and development in mental health treatments.
Conclusion
Elena Kagan's contributions to the field of medicine, particularly in the treatment of major depressive disorder, highlight her role as a leading inventor. Her patents and collaborations reflect her commitment to improving mental health care through innovative solutions.